David Knight

3.7k total citations · 1 hit paper
103 papers, 2.5k citations indexed

About

David Knight is a scholar working on History and Philosophy of Science, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David Knight has authored 103 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in History and Philosophy of Science, 17 papers in Molecular Biology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David Knight's work include History of Science and Natural History (12 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and History and advancements in chemistry (6 papers). David Knight is often cited by papers focused on History of Science and Natural History (12 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and History and advancements in chemistry (6 papers). David Knight collaborates with scholars based in United Kingdom, United States and Sweden. David Knight's co-authors include John Ghrayeb, G M Ringold, Alger B. Chapman, Peter E. Daddona, Margaret McDonough, Junming Le, Bernard J. Scallon, J Vilček, Scott A. Siegel and David J. Shealy and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

David Knight

88 papers receiving 2.3k citations

Hit Papers

Construction and initial characterization of a mouse-huma... 1993 2026 2004 2015 1993 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Knight United Kingdom 22 810 495 442 344 330 103 2.5k
Aldur W. Eriksson Finland 30 1.5k 1.8× 167 0.3× 712 1.6× 250 0.7× 141 0.4× 192 3.6k
L. Beckman Sweden 29 1.1k 1.4× 214 0.4× 1.1k 2.5× 257 0.7× 182 0.6× 202 4.4k
Jean Michaud Canada 29 1.5k 1.8× 361 0.7× 301 0.7× 87 0.3× 642 1.9× 176 4.5k
Ronald J. Trent Australia 32 1.4k 1.7× 1.5k 3.1× 1.1k 2.5× 391 1.1× 186 0.6× 162 4.8k
Jean‐Jacques Cassiman Belgium 37 2.0k 2.5× 584 1.2× 990 2.2× 148 0.4× 188 0.6× 185 4.9k
Moses S. Schanfield United States 22 604 0.7× 368 0.7× 1.1k 2.5× 185 0.5× 195 0.6× 88 2.2k
Marianne Schwartz Denmark 40 3.2k 4.0× 482 1.0× 1.2k 2.6× 168 0.5× 281 0.9× 116 4.9k
Elaine A. Muchmore United States 21 1.6k 1.9× 367 0.7× 486 1.1× 268 0.8× 267 0.8× 41 2.6k
David Morris United Kingdom 29 780 1.0× 1.1k 2.1× 423 1.0× 283 0.8× 171 0.5× 118 2.9k
Eun Young Song South Korea 34 1.0k 1.2× 779 1.6× 301 0.7× 110 0.3× 548 1.7× 211 3.8k

Countries citing papers authored by David Knight

Since Specialization
Citations

This map shows the geographic impact of David Knight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Knight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Knight more than expected).

Fields of papers citing papers by David Knight

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Knight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Knight. The network helps show where David Knight may publish in the future.

Co-authorship network of co-authors of David Knight

This figure shows the co-authorship network connecting the top 25 collaborators of David Knight. A scholar is included among the top collaborators of David Knight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Knight. David Knight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Knight, David. (2014). Veterans In Congress: The Policy Impact of Veterans in the U.S. House of Representatives. DigitalGeorgetown (Georgetown University Library).
2.
Shi, Lei, J. C. Wheeler, Raymond W. Sweet, et al.. (2010). De Novo Selection of High-Affinity Antibodies from Synthetic Fab Libraries Displayed on Phage as pIX Fusion Proteins. Journal of Molecular Biology. 397(2). 385–396. 50 indexed citations
3.
Brezski, Randall J., Jennifer L. Luongo, Mary Ryan, et al.. (2008). Human Anti-IgG1 Hinge Autoantibodies Reconstitute the Effector Functions of Proteolytically Inactivated IgGs. The Journal of Immunology. 181(5). 3183–3192. 38 indexed citations
4.
Knight, David. (2007). Kinds of minds. Nature. 447(7141). 149–149. 1 indexed citations
5.
Lowry, Christopher A., Jacob H. Hollis, Annick de Vries, et al.. (2007). Identification of an immune-responsive mesolimbocortical serotonergic system: Potential role in regulation of emotional behavior. Neuroscience. 146(2). 756–772. 126 indexed citations
6.
Evans, Andrew K., J.K. Abrams, J. Adriaan Bouwknecht, et al.. (2006). The anxiogenic drug FG-7142 increases serotonin metabolism in the rat medial prefrontal cortex. Pharmacology Biochemistry and Behavior. 84(2). 266–274. 17 indexed citations
7.
Knight, David, Robert E. Jordan, Marian Kruszynski, et al.. (2004). Pharmacodynamic enhancement of the anti-platelet antibody Fab abciximab by site-specific pegylation. Platelets. 15(7). 409–418. 19 indexed citations
8.
Knight, David, et al.. (2000). Sorting of the vasopressin prohormone into the regulated secretory pathway. FEBS Letters. 475(3). 175–180. 28 indexed citations
9.
Knight, David. (2000). Humphry Davy: science and social mobility. Endeavour. 24(4). 165–169. 1 indexed citations
10.
Wilson, Y.G., Alun H. Davies, Kay M. Southgate, et al.. (1996). Influence of Angioscopic Vein Graft Preparation on Development of Neointimal Hyperplasia in an Organ Culture Model of Human Saphenous Vein. Journal of Endovascular Surgery. 3(4). 436–444. 13 indexed citations
11.
Jeremy, Jamie Y., Mohammad Bashar Izzat, Sonia D. Birkett, et al.. (1996). Reduced prostacyclin and increased leukotriene B4 synthesis in porcine venous-arterial grafts. The Annals of Thoracic Surgery. 61(1). 143–148. 16 indexed citations
12.
Taylor, Alexander H., George A. Heavner, Mark Nedelman, et al.. (1995). Lipopolysaccharide (LPS) Neutralizing Peptides Reveal a Lipid A Binding Site of LPS Binding Protein. Journal of Biological Chemistry. 270(30). 17934–17938. 66 indexed citations
13.
Knight, David, Carrie Wagner, Robert E. Jordan, et al.. (1995). The immunogenicity of the 7E3 murine monoclonal Fab antibody fragment variable region is dramatically reduced in humans by substitution of human for murine constant regions. Molecular Immunology. 32(16). 1271–1281. 68 indexed citations
14.
Knight, David, Han Trinh, Junming Le, et al.. (1993). Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Molecular Immunology. 30(16). 1443–1453. 568 indexed citations breakdown →
15.
Dalesandro, Margaret R., Susan H. Tam, James E. Looney, et al.. (1993). Effects of isotype and Fc region on in vitro function of a mouse/human chimeric CD4 antibody. International Immunology. 5(3). 283–291. 7 indexed citations
16.
Knight, David, et al.. (1987). Requirements for Triggering of Adipocyte Differentiation by Glucocorticoids and Indomethacin*. Molecular Endocrinology. 1(1). 36–43. 50 indexed citations
17.
Knight, David. (1970). The Physical Sciences and the Romantic Movement. History of Science. 9(1). 54–75. 6 indexed citations
18.
Knight, David. (1968). Classical scientific papers : chemistry. Elsevier eBooks. 7 indexed citations
19.
Knight, David. (1967). Uniformity and Diversity of Nature in 17th Century Treatises on Plurality of Worlds. Organon. 1 indexed citations
20.
Knight, David. (1962). Suarez's Approach to Substantial Form. The Modern Schoolman. 39(3). 219–239. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026